Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Kreiter

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Cancer Research|January 13, 2012
Exploiting the mutanome for tumor vaccinationJohn C Castle, Sebastian Kreiter, Jan Diekmann, et al.
Oncoimmunology|February 21, 2022
An Fc-inert PD-L1×4-1BB bispecific antibody mediates potent anti-tumor immunity in mice by combining checkpoint inhibition and conditional 4-1BB co-stimulationAlexander Muik, Isil Altintas, Friederike Gieseke, et al.
Journal for Immunotherapy of Cancer|June 10, 2022
DuoBody-CD40x4-1BB induces dendritic-cell maturation and enhances T-cell activation through conditional CD40 and 4-1BB agonist activityAlexander Muik, Homer C Adams 3rd, Friederike Gieseke, et al.
Communications Biology|May 19, 2026
The MYB-related transcription factor MYPOP acts as a selective regulator of cancer cell growthJohannes Strunk, Alena Hüppner, Mahwish Sial, et al.
Nature|June 10, 2016
Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapyLena M Kranz, Mustafa Diken, Heinrich Haas, et al.
Science Translational Medicine|September 13, 2021
Local delivery of mRNA-encoded cytokines promotes antitumor immunity and tumor eradication across multiple preclinical tumor modelsChristian Hotz, Timothy R Wagenaar, Friederike Gieseke, et al.
Molecular & Cellular Proteomics : MCP|June 3, 2019
Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and PlasmaBracha Shraibman, Eilon Barnea, Dganit Melamed Kadosh, et al.
Molecular & Cellular Proteomics : MCP|August 4, 2018
Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and PlasmaBracha Shraibman, Eilon Barnea, Dganit Melamed Kadosh, et al.
Cancer Discovery|February 17, 2022
Preclinical Characterization and Phase I Trial Results of a Bispecific Antibody Targeting PD-L1 and 4-1BB (GEN1046) in Patients with Advanced Refractory Solid TumorsAlexander Muik, Elena Garralda, Isil Altintas, et al.
Nature|July 31, 2020
An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanomaUgur Sahin, Petra Oehm, Evelyna Derhovanessian, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Cancer Research|January 13, 2012
Exploiting the mutanome for tumor vaccinationJohn C Castle, Sebastian Kreiter, Jan Diekmann, et al.
Oncoimmunology|February 21, 2022
An Fc-inert PD-L1×4-1BB bispecific antibody mediates potent anti-tumor immunity in mice by combining checkpoint inhibition and conditional 4-1BB co-stimulationAlexander Muik, Isil Altintas, Friederike Gieseke, et al.
Journal for Immunotherapy of Cancer|June 10, 2022
DuoBody-CD40x4-1BB induces dendritic-cell maturation and enhances T-cell activation through conditional CD40 and 4-1BB agonist activityAlexander Muik, Homer C Adams 3rd, Friederike Gieseke, et al.
Communications Biology|May 19, 2026
The MYB-related transcription factor MYPOP acts as a selective regulator of cancer cell growthJohannes Strunk, Alena Hüppner, Mahwish Sial, et al.
Nature|June 10, 2016
Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapyLena M Kranz, Mustafa Diken, Heinrich Haas, et al.
Science Translational Medicine|September 13, 2021
Local delivery of mRNA-encoded cytokines promotes antitumor immunity and tumor eradication across multiple preclinical tumor modelsChristian Hotz, Timothy R Wagenaar, Friederike Gieseke, et al.
Molecular & Cellular Proteomics : MCP|June 3, 2019
Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and PlasmaBracha Shraibman, Eilon Barnea, Dganit Melamed Kadosh, et al.
Molecular & Cellular Proteomics : MCP|August 4, 2018
Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and PlasmaBracha Shraibman, Eilon Barnea, Dganit Melamed Kadosh, et al.
Cancer Discovery|February 17, 2022
Preclinical Characterization and Phase I Trial Results of a Bispecific Antibody Targeting PD-L1 and 4-1BB (GEN1046) in Patients with Advanced Refractory Solid TumorsAlexander Muik, Elena Garralda, Isil Altintas, et al.
Nature|July 31, 2020
An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanomaUgur Sahin, Petra Oehm, Evelyna Derhovanessian, et al.
Pageof 6